scispace - formally typeset
K

Kari R. Fischer

Researcher at Cornell University

Publications -  5
Citations -  1590

Kari R. Fischer is an academic researcher from Cornell University. The author has contributed to research in topics: Metastasis & Cancer. The author has an hindex of 4, co-authored 5 publications receiving 1341 citations.

Papers
More filters
Journal ArticleDOI

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

TL;DR: The potential of an EMT-targeting strategy, in conjunction with conventional chemotherapies, for breast cancer treatment is suggested, using a mesenchymal-specific Cre-mediated fluorescent marker switch system in spontaneous breast-to-lung metastasis models.
Journal ArticleDOI

In Vivo Visualization and Characterization of Epithelial–Mesenchymal Transition in Breast Tumors

TL;DR: An in vivo approach to track the fate of tumor cells based on a novel EMT-driven fluorescent color switching breast cancer mouse model and intravital two-photon laser scanning microscopy provides a novel opportunity for visualizing tumor EMT at the single-cell level and may reveal the intricacies underlying tumor dynamics and treatment responses.
Journal ArticleDOI

Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC.

TL;DR: Analysis of homogeneousStromal populations isolated directly from fresh clinical specimens can detect important stromal genes of therapeutic value and enhanced tumorigenic properties of lung cancer cells indicative of their potential as targets for therapy are demonstrated.
Journal ArticleDOI

Fischer et al . reply

TL;DR: It is shown that the absence of Fto protein results in leanness and that Fto deficiency affects energy homeostasis and the experiments performed in mice conflict with results in humans carrying the FTO risk allele presenting hyperphagia and increased caloric intake.
Proceedings ArticleDOI

Abstract 4721: Epithelial to mesenchymal transition is not required for breast to lung metastasis but contributes to chemoresistance

TL;DR: A novel and unique EMT lineage tracing system is established in spontaneous breast to lung metastasis models and suggests the potential of an EMT-targeting strategy, in conjunction with conventional chemotherapies, in the treatment of breast cancer patients.